I agree senti, but a NICE decision may take longer than some here suggest. NICE still hasn’t caught up with the new expedited licensing routes in the UK, and if this recent debate is any indication, it does not appear that the situation will improve anytime soon:
UK Parliament Debate on Cancer Drugs: Licensing and Approval Volume 815: debated on Monday 8 November 2021